355 related articles for article (PubMed ID: 9512478)
1. Oxidation of high-density lipoprotein HDL3 leads to exposure of apo-AI and apo-AII epitopes and to formation of aldehyde protein adducts, and influences binding of oxidized low-density lipoprotein to type I and type III collagen in vitro1.
Greilberger J; Jürgens G
Biochem J; 1998 Apr; 331 ( Pt 1)(Pt 1):185-91. PubMed ID: 9512478
[TBL] [Abstract][Full Text] [Related]
2. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function.
Kempen HJ; van Gent CM; Buytenhek R; Buis B
J Lab Clin Med; 1987 Jan; 109(1):19-26. PubMed ID: 3098880
[TBL] [Abstract][Full Text] [Related]
3. Conversion of apolipoprotein-specific high-density lipoprotein populations during incubation of human plasma.
Nichols AV; Blanche PJ; Shore VG; Gong EL
Biochim Biophys Acta; 1989 Feb; 1001(3):325-37. PubMed ID: 2492827
[TBL] [Abstract][Full Text] [Related]
4. The role of apoproteins AI and AII in binding of high-density lipoprotein3 to membranes derived from bovine aortic endothelial cells.
Vadiveloo PK; Fidge NH
Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):145-51. PubMed ID: 1599393
[TBL] [Abstract][Full Text] [Related]
5. Studies on epitopes on low-density lipoprotein modified by 4-hydroxynonenal. Biochemical characterization and determination.
Chen Q; Esterbauer H; Jürgens G
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):249-54. PubMed ID: 1280111
[TBL] [Abstract][Full Text] [Related]
6. High-density lipoprotein 3 physicochemical modifications induced by interaction with human polymorphonuclear leucocytes affect their ability to remove cholesterol from cells.
Cogny A; Atger V; Paul JL; Soni T; Moatti N
Biochem J; 1996 Feb; 314 ( Pt 1)(Pt 1):285-92. PubMed ID: 8660296
[TBL] [Abstract][Full Text] [Related]
7. Characterization of high density lipoprotein binding to human adipocyte plasma membranes.
Fong BS; Rodrigues PO; Salter AM; Yip BP; Despres JP; Angel A; Gregg RE
J Clin Invest; 1985 Jun; 75(6):1804-12. PubMed ID: 2989332
[TBL] [Abstract][Full Text] [Related]
8. Characterization of high-density lipoprotein binding and cholesterol efflux in cultured mouse adipose cells.
Barbaras R; Grimaldi P; Negrel R; Ailhaud G
Biochim Biophys Acta; 1986 Sep; 888(2):143-56. PubMed ID: 3017445
[TBL] [Abstract][Full Text] [Related]
9. Effect of the human cholesteryl ester transfer protein on the particle size redistribution of specific subpopulations of high density lipoproteins-3.
Lagrost L
Biochim Biophys Acta; 1992 Jun; 1126(2):143-50. PubMed ID: 1627616
[TBL] [Abstract][Full Text] [Related]
10. Characterization of monoclonal antibodies against apolipoproteins A-I and A-II. Epitope expression in LpA-I and LpA-I:A-II particles.
Ulloa N; Bustos P; Castro G; Fruchart J; Vera M; Fruchart JC; Calvo C
Hybridoma; 1999 Dec; 18(6):513-20. PubMed ID: 10626680
[TBL] [Abstract][Full Text] [Related]
11. Immunoaffinity fractionation of high-density lipoprotein subclasses 2 and 3 using anti-apolipoprotein A-I and A-II immunosorbent gels.
James RW; Proudfoot A; Pometta D
Biochim Biophys Acta; 1989 Apr; 1002(3):292-301. PubMed ID: 2469471
[TBL] [Abstract][Full Text] [Related]
12. Studies on the interaction between apolipoprotein A-II-enriched HDL3 and cultured bovine aortic endothelial (BAE) cells.
Vadiveloo PK; Fidge NH
Biochim Biophys Acta; 1990 Jul; 1045(2):135-41. PubMed ID: 2116175
[TBL] [Abstract][Full Text] [Related]
13. Studies on the proteins involved in the interaction of high-density lipoprotein with isolated human small intestine epithelial cells.
Sviridov DD; Ehnholm C; Tenkanen H; Pavlov MYu ; Safonova IG; Repin VS
FEBS Lett; 1992 Jun; 303(2-3):202-4. PubMed ID: 1607020
[TBL] [Abstract][Full Text] [Related]
14. Interaction between high-density lipoprotein subpopulations in apo B-free and abetalipoproteinemic plasma.
Cheung MC; Wolf AC; Illingworth DR
Biochim Biophys Acta; 1992 Oct; 1128(2-3):244-9. PubMed ID: 1420297
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein AI and AII metabolism in patients with primary high-density lipoprotein deficiency associated with familial hypertriglyceridemia.
Saku K; Gartside PS; Hynd BA; Mendoza SG; Kashyap ML
Metabolism; 1985 Aug; 34(8):754-64. PubMed ID: 3927110
[TBL] [Abstract][Full Text] [Related]
16. Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein.
Requena JR; Fu MX; Ahmed MU; Jenkins AJ; Lyons TJ; Baynes JW; Thorpe SR
Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):317-25. PubMed ID: 9078279
[TBL] [Abstract][Full Text] [Related]
17. The C-terminal helix of human apolipoprotein AII promotes the fusion of unilamellar liposomes and displaces apolipoprotein AI from high-density lipoproteins.
Lambert G; Decout A; Vanloo B; Rouy D; Duverger N; Kalopissis A; Vandekerckhove J; Chambaz J; Brasseur R; Rosseneu M
Eur J Biochem; 1998 Apr; 253(1):328-38. PubMed ID: 9578492
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein.
Graham A; Hassall DG; Rafique S; Owen JS
Atherosclerosis; 1997 Dec; 135(2):193-204. PubMed ID: 9430369
[TBL] [Abstract][Full Text] [Related]
19. Binding of apolipoprotein A-I and A-II after recombination with phospholipid vesicles to the high density lipoprotein receptor of luteinized rat ovary.
Hwang J; Menon KM
J Biol Chem; 1985 May; 260(9):5660-8. PubMed ID: 2985608
[TBL] [Abstract][Full Text] [Related]
20. Expression of the human serum apolipoprotein AI and AII genes in Xenopus laevis oocytes. Lipid-associated secretion of gene products.
Haase A; Stoffel W
Biol Chem Hoppe Seyler; 1988 Jul; 369(7):585-93. PubMed ID: 2852015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
